This ultimately restores ovarian cancer cell susceptibility to cisplatin-induced pyroptosis, shed light on the crucial role of CRLF1’s adaptor function in regulating AKT activation and chemoresistance. Here, CRLF1 is linked to ovarian carcinoma.